China Corona Virus Outbreak

[_Cathy_]

Natatawa ako sa friends ko na A4 super conscious sa antok na na feel nila sa Sinovac. Paano pa kaya kung worse symptoms. Naalala ko tuloy sabi ni kags about mahinang nilalang [emoji23]

Sent from my SM-N960F using Tapatalk

[cast_no_shadow]

Natatawa ako sa friends ko na A4 super conscious sa antok na na feel nila sa Sinovac. Paano pa kaya kung worse symptoms. Naalala ko tuloy sabi ni kags about mahinang nilalang [emoji23]

Sent from my SM-N960F using Tapatalk

Mga officemates ko ganyan din, buti nga daw naka drive pa sila pauwi [emoji23]


Sent from my iPhone using Tapatalk

[viper888]

Good for them

I got a 2 day fever from AZ


Sent from my iPad using Tapatalk

[dr. d]

If aalisin mo yung singitan at padrino? Okay na ako sa sistema niya.

Kaso in a perfect world yun.

May singit / prioritization din naman dyan sa appointment system. Hindi mo lang ramdam dahil hindi ka nga nakapila.

i am reminded,
last week,
there was a "free vaccination" scheduled at a mall in manila.
nag-complain ang iba, dahil kahit maaga silang pumila, ay ubos daw agad.
may nag-sumbong, totoo o hinde, hindi ko alam, na the organizer prioritized the mall employees over the commoners...

[cast_no_shadow]

i am reminded,
last week,
there was a "free vaccination" scheduled at a mall in manila.
nag-complain ang iba, dahil kahit maaga silang pumila, ay ubos daw agad.
may nag-sumbong, totoo o hinde, na the organizer prioritized the mall employees over the commoners...

Which is given na nga din naman, lamang ang insiders. Nababasa ko nga din parang 2K doses per mall, around 10am ubos na ang slots.

Same case doon sa kuwento ko sa hospital site naman. Kako I can understand na may ganyan pero ginarapal eh? Hindi nilagyan ng sistema para mabutasan nila ng madali.

Ang simple kako, may line for seniors and PWD, may line for regulars (A3 and A4) tapos tsaka sila mag gawa ng line for their VIPs. Kaso hindi sama sama sa isang line, kaya yung bilang ko na pang 30 ako langya nalipat sa 50+.

visible din masyado yung kararating lang tapos diretso agad sa loob.


Sent from my iPhone using Tapatalk

[Dr.Kamiya]

i am reminded,
last week,
there was a "free vaccination" scheduled at a mall in manila.
nag-complain ang iba, dahil kahit maaga silang pumila, ay ubos daw agad.
may nag-sumbong, totoo o hinde, hindi ko alam, na the organizer prioritized the mall employees over the commoners...

For me ok lang to prioritize the mall employees. Those guys interact with huge numbers of strangers day-in and day-out.
Net effect on community safety is much higher vaccinating a mall employee than someone who will mostly stay at home.

Maybe they should have been more transparent about what they were doing but I don't think it was wrong.

[Flipo]

Taking a closer look at Chinese vaccines | Philstar.com

Taking a closer look at Chinese vaccines
POSTSCRIPT - Federico D. Pascual Jr. (The Philippine Star) - June 13, 2021 - 12:00am

We’re afforded “a closer look at China’s vaccines” in a report June 10 by Jonathan Wolfe of The New York Times’ briefings team on the COVID-19 pandemic, with inputs from his colleague Sui-Lee Wee who covers China.

The World Health Organization has granted emergency use listing to two of China’s vaccines – one from the state-owned company Sinopharm and the other from Sinovac, a private firm based in Beijing.

The Chinese vaccines have come under scrutiny recently after cases rose in such places as Bahrain, Mongolia and the Seychelles – where large percentages of the population had been inoculated with the Sinopharm vaccine.

The Sinopharm vaccine has a 78 percent efficacy rating while the Sinovac vaccine has a range of 50 to 78 percent, depending on where the clinical trial was done. One issue is that the WHO said it doesn’t have enough data on how the vaccines affect people above 60 years old.

The Phase 3 clinical trial for Sinopharm was done in the United Arab Emirates, where 90 percent of the vaccinees were middle-aged men. And it was very similar for Sinovac.

The leading exporter of coronavirus vaccines, China has delivered more than 250 million doses to 90-plus countries, many of them in Latin America and Asia-Pacific, including the Philippines.

Wolfe wrote: “China says that these vaccines still prevent severe illness and death which, by all accounts, they do. Even in the Seychelles, all the people I interviewed who had COVID after getting the Sinopharm vaccine said that they have had mild symptoms and were able to recover at home.

“But some experts have said that because the Chinese vaccines lag behind Western vaccines such as Pfizer and Moderna in terms of efficacy, that means that countries that choose to use them will take longer to reach herd immunity.

“A couple of experts have done some modeling that shows that basically, if you use a vaccine with 90 percent efficacy against infection, that means you can reach herd immunity if 66 percent of the population is vaccinated.

“But if you use a lower efficacy vaccine, you need many more people to be vaccinated. So, for example, if the vaccine is 60 percent effective, then the portion of the population that needs to be vaccinated is 100 percent.

“That’s the real issue with the Chinese vaccines. They’re very useful for countries in preventing severe illness and death, but if you want to reopen the economy quickly, they would need to reassess whether using a Chinese vaccine is the best bet for them.

“What do developing countries that are receiving the Chinese vaccines think about them?

“At this point, a lot of them don’t have a choice. At the end of the day, China is a country that says it can make five billion doses a year. And with the Pfizer and Moderna vaccines, the developed nations are still ahead in the queue.

“What do we know about how well they protect against the variants?

“Not much, actually. The SinoVac vaccine is 50 percent against the Gamma variant in Brazil. Sinopharm said that a small-scale study showed that it could protect against the Beta variant that first appeared in South Africa, but there was some reduction in the protection. But that was such a small lab study.”

G7 nations donating 1-B COVID shots

In its June 11 report on President Biden’s announcing a US donation of 500 million doses of Pfizer vaccines, the NYT said vaccinating the world is a major topic at the G7 meeting that began Friday in Cornwall, England.

The wealthy democracies – the US, Canada, Japan, Britain, France, Germany and Italy – have COVID-19 more or less under control within their borders but the coronavirus and its variants are still a serious threat in many parts of the globe.

Together, the G7 members are expected to donate one billion doses that are likely to go to Latin America and to parts of Africa, Asia and the Middle East. The vaccines reportedly cost from $5 to $7 per dose.

Some of the G7 donations may come from the excess stock that the US and some European countries snapped up at the early stages of the pandemic that saw rich nations scrambling for supplies.

(FDP: Secretary Carlito Galvez Jr., chief of the COVID-19 task force, testified in the Senate in February that the Sinovac vaccine that the administration was buying cost around P3,000 ($60) for two doses. That is way above the reported $7 current price of Pfizer.

(These prices were listed late last year by the health department: Novavax, P366 per 2 doses; AstraZeneca, P610; Covax Facility, P854; Sputnik V, P1,220; Pfizer, P2,379; Moderna, P3,904-P4,504; and Sinovac, P3,629.50. The prices included value-added tax and contingency for 10-percent “inflation.”

(Galvez was asked why Sinovac carried a price tag of more than P3,600 while Indonesia reportedly paid only the equivalent of P700. He said there were many factors but could not discuss them without violating the confidentiality clause in the contract.)

More Pfizer vax arrive from COVAX

In Manila, meanwhile, the second batch of 2,282,850 doses of Pfizer-BioNTech vaccines arrived June 10 through COVAX, a worldwide initiative aimed at equitable access to the vaccines. The Philippines has received more than five million doses through it.

The first tranche of 193,050 Pfizer doses arrived May 10. Of the new delivery, 1.86 million will go to Manila, 210,600 to Cebu and 210,600 to Davao. In total, COVAX will provide 44 million doses, enough to vaccinate one in five Filipinos.

The US is the largest contributor to the COVAX Advance Market Commitment. In February, the US announced a total planned contribution of P195 billion ($4 billion) to the COVAX Facility.

US embassy Chargé d’Affaires John Law joined Health Secretary Francisco Duque, Secretary Galvez, Chief of Presidential Protocol Robert Borje and other officials in the group that received the vaccines.

[dr. d]

For me ok lang to prioritize the mall employees. Those guys interact with huge numbers of strangers day-in and day-out.
Net effect on community safety is much higher vaccinating a mall employee than someone who will mostly stay at home.

Maybe they should have been more transparent about what they were doing but I don't think it was wrong.

i think it was personal gain masquerading as public service.
they should have done pre-registration, and only those who made it to the cut-off be allowed to fall in line.
huwag nang pa-asahin at pagurin yung wala naman talagang pag-asa.

but that's just me.

[dr. d]

Taking a closer look at Chinese vaccines | Philstar.com

Taking a closer look at Chinese vaccines
POSTSCRIPT - Federico D. Pascual Jr. (The Philippine Star) - June 13, 2021 - 12:00am

We’re afforded “a closer look at China’s vaccines” in a report June 10 by Jonathan Wolfe of The New York Times’ briefings team on the COVID-19 pandemic, with inputs from his colleague Sui-Lee Wee who covers China.

The World Health Organization has granted emergency use listing to two of China’s vaccines – one from the state-owned company Sinopharm and the other from Sinovac, a private firm based in Beijing.

The Chinese vaccines have come under scrutiny recently after cases rose in such places as Bahrain, Mongolia and the Seychelles – where large percentages of the population had been inoculated with the Sinopharm vaccine.

The Sinopharm vaccine has a 78 percent efficacy rating while the Sinovac vaccine has a range of 50 to 78 percent, depending on where the clinical trial was done. One issue is that the WHO said it doesn’t have enough data on how the vaccines affect people above 60 years old.

The Phase 3 clinical trial for Sinopharm was done in the United Arab Emirates, where 90 percent of the vaccinees were middle-aged men. And it was very similar for Sinovac.

The leading exporter of coronavirus vaccines, China has delivered more than 250 million doses to 90-plus countries, many of them in Latin America and Asia-Pacific, including the Philippines.

Wolfe wrote: “China says that these vaccines still prevent severe illness and death which, by all accounts, they do. Even in the Seychelles, all the people I interviewed who had COVID after getting the Sinopharm vaccine said that they have had mild symptoms and were able to recover at home.

“But some experts have said that because the Chinese vaccines lag behind Western vaccines such as Pfizer and Moderna in terms of efficacy, that means that countries that choose to use them will take longer to reach herd immunity.

“A couple of experts have done some modeling that shows that basically, if you use a vaccine with 90 percent efficacy against infection, that means you can reach herd immunity if 66 percent of the population is vaccinated.

“But if you use a lower efficacy vaccine, you need many more people to be vaccinated. So, for example, if the vaccine is 60 percent effective, then the portion of the population that needs to be vaccinated is 100 percent.

“That’s the real issue with the Chinese vaccines. They’re very useful for countries in preventing severe illness and death, but if you want to reopen the economy quickly, they would need to reassess whether using a Chinese vaccine is the best bet for them.

“What do developing countries that are receiving the Chinese vaccines think about them?

“At this point, a lot of them don’t have a choice. At the end of the day, China is a country that says it can make five billion doses a year. And with the Pfizer and Moderna vaccines, the developed nations are still ahead in the queue.

“What do we know about how well they protect against the variants?

“Not much, actually. The SinoVac vaccine is 50 percent against the Gamma variant in Brazil. Sinopharm said that a small-scale study showed that it could protect against the Beta variant that first appeared in South Africa, but there was some reduction in the protection. But that was such a small lab study.”

G7 nations donating 1-B COVID shots

In its June 11 report on President Biden’s announcing a US donation of 500 million doses of Pfizer vaccines, the NYT said vaccinating the world is a major topic at the G7 meeting that began Friday in Cornwall, England.

The wealthy democracies – the US, Canada, Japan, Britain, France, Germany and Italy – have COVID-19 more or less under control within their borders but the coronavirus and its variants are still a serious threat in many parts of the globe.

Together, the G7 members are expected to donate one billion doses that are likely to go to Latin America and to parts of Africa, Asia and the Middle East. The vaccines reportedly cost from $5 to $7 per dose.

Some of the G7 donations may come from the excess stock that the US and some European countries snapped up at the early stages of the pandemic that saw rich nations scrambling for supplies.

(FDP: Secretary Carlito Galvez Jr., chief of the COVID-19 task force, testified in the Senate in February that the Sinovac vaccine that the administration was buying cost around P3,000 ($60) for two doses. That is way above the reported $7 current price of Pfizer.

(These prices were listed late last year by the health department: Novavax, P366 per 2 doses; AstraZeneca, P610; Covax Facility, P854; Sputnik V, P1,220; Pfizer, P2,379; Moderna, P3,904-P4,504; and Sinovac, P3,629.50. The prices included value-added tax and contingency for 10-percent “inflation.”

(Galvez was asked why Sinovac carried a price tag of more than P3,600 while Indonesia reportedly paid only the equivalent of P700. He said there were many factors but could not discuss them without violating the confidentiality clause in the contract.)

More Pfizer vax arrive from COVAX

In Manila, meanwhile, the second batch of 2,282,850 doses of Pfizer-BioNTech vaccines arrived June 10 through COVAX, a worldwide initiative aimed at equitable access to the vaccines. The Philippines has received more than five million doses through it.

The first tranche of 193,050 Pfizer doses arrived May 10. Of the new delivery, 1.86 million will go to Manila, 210,600 to Cebu and 210,600 to Davao. In total, COVAX will provide 44 million doses, enough to vaccinate one in five Filipinos.

The US is the largest contributor to the COVAX Advance Market Commitment. In February, the US announced a total planned contribution of P195 billion ($4 billion) to the COVAX Facility.

US embassy Chargé d’Affaires John Law joined Health Secretary Francisco Duque, Secretary Galvez, Chief of Presidential Protocol Robert Borje and other officials in the group that received the vaccines.

sometimes, the bigger hurdle to achieving any form of herd immunity, is not the vaccine.
it is the negative public. they may not seem to perceive, that when they refuse an available vaccine, they are contributing to the non-herdance of immunity.

[bloowolf]

Which goes to prove that a product need not to be free to be accepted by the public.
Sent from my iPad using Tapatalk

[dr. d]

Which goes to prove that a product need not to be free to be accepted by the public.
Sent from my iPad using Tapatalk

many are willing to pay top rupiah, for the "right" product.

[bloowolf]

many are willing to pay top rupiah, for the "right" product.

many are willing to pay top rupiah, for the "right" product.

For those who can afford to. But a lot of those who decline are in the low income group whose most current source of information are the tricycle drivers. On the opposite end of the pole are the priviledged who get their info from mostly the social media they prefer & would rather take IVM.


Sent from my iPad using Tapatalk

[viper888]

To be fair, many have reluctantly taken Sinovac. Basically 50.4%, 83%, or 67% is far better than 0%

Our problem are the workers, basically none of them want to take. Also our village guards, only 1/5 are willing.


Sent from my iPhone using Tapatalk

[dr. d]

For those who can afford to. But a lot of those who decline are in the low income group whose most current source of information are the tricycle drivers. On the opposite end of the pole are the priviledged who get their info from mostly the social media they prefer & would rather take IVM.


Sent from my iPad using Tapatalk

IVM.
i heard, the indian government, without benefit of expensive and time-consuming decision-basing activities, simply removed it and other drugs, from their list of anti-covid armamentarium.
is our country spending millions, to make IVM available to the populace, on the say-so of some politicians?

[H1Tman]

IVM.
i heard, the indian government, without benefit of expensive and time-consuming decision-basing activities, simply removed it and other drugs, from their list of anti-covid armamentarium.
is our country spending millions, to make IVM available to the populace, on the say-so of some politicians?

Duterte asked FDA to do the study.


Sent from my iPhone using Tapatalk

[bloowolf]

IVM.
i heard, the indian government, without benefit of expensive and time-consuming decision-basing activities, simply removed it and other drugs, from their list of anti-covid armamentarium.
is our country spending millions, to make IVM available to the populace, on the say-so of some politicians?

At the time the ivm fanatics were pressuring the FDA to approve it as a covid treatment/preventive, the FDA, under pressure, approved it “for human use against internal parasites” & the ivm group still protested. I found it so funny.


Sent from my iPad using Tapatalk

[bloowolf]

Duterte asked FDA to do the study.


Sent from my iPhone using Tapatalk

The FDA will depend on research by other international health bodies too.
But here India is sueing a WHO scientist

Indian Bar Association sues WHO scientist over Ivermectin | Columnists | thedesertreview.com

Sent from my iPad using Tapatalk

[dr. d]

Duterte asked FDA to do the study.


Sent from my iPhone using Tapatalk

and what did that study conclude, i wonder?
did they take into account, the indian activities?

[dr. d]

At the time the ivm fanatics were pressuring the FDA to approve it as a covid treatment/preventive, the FDA, under pressure, approved it “for human use against internal parasites” & the ivm group still protested. I found it so funny.


Sent from my iPad using Tapatalk

the local ivm voice has been quiet, lately...

i wonder,
how's the local sales and use of ivm against covid?
none of the covid cases i am aware of, are into ivm.
is there an increase in ivm-led purgation programs ?

many years ago,
there was note of an increase in the number of gastric ulcers among women... or more accurately, the increased sales of a certain anti-ulcer medication... until someone mentioned that said medication had an abortifacient-like side-effect...
OT. reminiscing.

[bloowolf]

the local ivm voice has been quiet, lately...

i wonder,
how's the local sales and use of ivm against covid?
none of the covid cases i am aware of, are into ivm.
is there an increase in ivm-led purgation programs ?

many years ago,
there was note of an increase in the number of gastric ulcers among women... or more accurately, the sales of a certain anti-ulcer medication... until someone mentioned that said medication had an abortifacient-like side-effect...

Not as noisy but, there still is. They claim there are a lot of doctors who take it themselves or used it when they were sick. These are all “I just heard” but on your end, are there some you know who claim it works?


Sent from my iPad using Tapatalk